🧵Check out our work JAHA on 3-year outcomes following septal myectomy in 5,300 obstructive HCM patients. High overall burden of CVH post-myectomy in this unselected HCM cohort from wide range of practices. AFib/flutter is major issues! 25% develop new AF/AFL within 1st

🔴Current and emerging treatment options for transthyretin amyloid cardiomyopathy⤵️ #2025Review Heart_BMJ 🔹heart.bmj.com/content/early/… #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX

Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC onlinelibrary.wiley.com/doi/10.1002/ej… #HFA European Society of Cardiology Journals Henry Han Amr Abdin Giuseppe Galati

The therapeutic landscape for cardiac amyloidosis is transforming. This latest JACC review summarises FDA-approved options, including tafamidis, acoramidis, and vutrisiran, alongside promising RNA-targeted agents like eplontersen. The authors explore how these advances shift

A must read: #Atrial #cardiomyopathy: A clinical consensus statement of the #HeartFailure Association of the #ESC👇 doi.org/10.1002/ejhf.3…

MAGNITUDE phase III trial: Nex-Z vs placebo in ATTR-CM, will increase sample size to 1200 patients #CardioTwitter

Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial In this post hoc analysis of VICTORIA, vericiguat compared with placebo significantly reduced the risk of cardiovascular death or HFH in patients with worsening

Impact of Vutrisiran on Cardiac Biomarkers in Patients With Transthyretin Amyloidosis With Cardiomyopathy From HELIOS-B: JACC Journals 😱 Biomarkers and ATTR-CM 👇👇👇

HEAT EXTREMES AND CARDIOVASCULAR DISEASE 🌡️New Scientific Document by 8 European Society of Cardiology associations/groups 🌡️9 pages 🌡️14 auhtors 🌡️93 key references A must-read in this summer-period of so many heawaves lnkd.in/dZVmiQJH #heatwave #globalwarming #CVD #esccongress #WCCardio

The way you access cardiology clinical guidance is about to change. Get ready for ESC Chat – a cutting-edge, conversational tool powered only by ESC Practice Guidelines. Fast, reliable and created for real-world practice, it delivers instant answers to reduce uncertainty,

New #JACCBTS study: In #ATTR, myocardium generates less force per area due to reduced contractile tissue, with higher Ca²⁺ sensitivity likely from TnI dephosphorylation. Findings point to both intra- and extracellular drivers of dysfunction. jacc.org/doi/10.1016/j.… #Amyloidosis

Let’s bring atrial dysfunction into focus—before failure occurs. 📖 Open access: doi.org/10.1002/ejhf.3… #CardioTwitter #AtrialFailure #ESC #HFAyoung #HeartFailure #AFib #CardioTwitter #Cardiology

🚨🇮🇹New multicenter Italian study on early-stage ATTRwt-CM treated with tafamidis: clinical & biochemical markers help identify high-risk cases🫀 📣out in JACC: HF jacc.org/doi/epdf/10.10… Alberto Cipriani Amyloidosis_papers Università di Padova

Cardiac Amyloidosis: Historically, neurohormonal antagonists were considered contraindicated owing to concerns about autonomic dysfunction & chronotropic incompetence. However, recent evidence suggests a paradigm shift… cfrjournal.com/articles/heart…

Rationale and Design of the Dapagliflozin Effect on Cardiovascular Events in Acute Heart Failure (DAPA ACT HF)-TIMI 68 Trial DAPA ACT HF-TIMI 68 is a cardiovascular outcomes trial evaluating the initiation of dapagliflozin vs placebo in patients hospitalized for the management

Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics Beta-blockers remain first-line therapy for symptomatic oHCM despite limited evidence. MAPLE-HCM: phase 3 trial comparing aficamten vs metoprolol

The Perugini Grades After 20 Years: Time for a Modern Framework. With Wael Jaber Editorial for excellent paper from Sharmila Dorbala group showing similar prognosis between grade 2 and 3 in ATTR-CM sciencedirect.com/science/articl… journalofnuclearcardiology.org/article/S1071-…

🗞️ #HeartFailure attributed mortality in Europe, 2012–2021 European Society of Cardiology Journals Giuseppe Galati Amr Abdin Henry Han bit.ly/3HmmDxw

Great work here by Srihari S. Naidu, MD and all authors. Lots of work went into putting this together. Take a look when you have a chance #CardioTwitter

Late-Breaking Clinical Trials to Watch at #ESCcongress 2025 : Global Health and reshaping cardiovascular care priorities 📣Heart Failure 📍#DAPA ACT HF-TIMI 68 – #SGLT2i initiated during acute HF hospitalization 📍#VICTOR & #VICTORIA – Expanding vericiguat’s role in chronic HF